Abstract | BACKGROUND: METHODS: Nine RT patients (eight women, one man) with allograft function more than 6 months were included based on total SCa more than 10.5 mg/dL and intact parathyroid hormone (iPTH) concentration more than 65 pg/mL. After inclusion, patients started on a single daily oral dose of 30 mg of cinacalcet. At inclusion and every study visit blood levels of creatinine, Ca, P, alkaline phosphatase, iPTH 1,25- dihydroxyvitamin D3, and 25-hydroxyvitamin D3 were assessed. Baseline and at the end of study radial BMD were measured. Study follow-up was 12 months. RESULTS: During the study period, SCa decreased from 11.72+/-0.39 to 10.03+/-0.54 mg/dL (P<0.001). iPTH decreased from 308.85+/-120.12 to 214.66+/-53.75 mg/dL (P<0.05). The mean serum creatinine decreased from 1.58+/-0.34 to 1.25+/-0.27 mg/dL (P=0.03) and the mean radial BMD increased from 0.881+/-0.155 to 0.965+/-0.123 gr/cm2 (P<0.05). There were no significant changes in the other parameters assessed. One patient was excluded for gastrointestinal intolerance. CONCLUSIONS:
|
Authors | Carlos Bergua, José-Vicente Torregrosa, David Fuster, Alex Gutierrez-Dalmau, Federico Oppenheimer, José M Campistol |
Journal | Transplantation
(Transplantation)
Vol. 86
Issue 3
Pg. 413-7
(Aug 15 2008)
ISSN: 0041-1337 [Print] United States |
PMID | 18698244
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Naphthalenes
- Parathyroid Hormone
- Phosphates
- Creatinine
- Alkaline Phosphatase
- Calcitriol
- Calcifediol
- Calcium
- Cinacalcet
|
Topics |
- Administration, Oral
- Aged
- Alkaline Phosphatase
(blood)
- Bone Density
(drug effects)
- Calcifediol
(blood)
- Calcitriol
(blood)
- Calcium
(blood)
- Cinacalcet
- Creatinine
(blood)
- Female
- Humans
- Hypercalcemia
(drug therapy, etiology, physiopathology)
- Hyperparathyroidism, Secondary
(drug therapy, etiology, physiopathology)
- Kidney Transplantation
(adverse effects)
- Male
- Middle Aged
- Naphthalenes
(administration & dosage, adverse effects, therapeutic use)
- Parathyroid Hormone
(blood)
- Phosphates
(blood)
- Prospective Studies
- Time Factors
- Treatment Outcome
|